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Abstract 
With 50% of patients in North America not taking their medications as they should 
(Brown & Bussell, 2011), a better understanding of medication adherence among older 
patients could be helpful to health professionals and service providers. The purpose of this 
study was to examine whether the perceived pharmacist-patient quality of communication is 
associated with diabetes medication adherence. Eighty-four adults (>60 years old) from the 
Primary Care Diabetes Support Program were recruited. Diabetes medication adherence and 
pharmacist-patient quality of communication were measured using self-report questionnaires. 
No significant correlation was found between medication adherence and perceived 
pharmacist-patient quality of communication. Results indicated a significant correlation 
between medication adherence and the number of years the patient had been diagnosed with 
diabetes (r=-0.233), as well as the number of medications the patient took (r=-0.284).  
Patients diagnosed with diabetes for a longer time and patients taking both injections and 
pills reported to be less adherent.  
 
Keywords  
Medication Adherence, Pharmacist-Patient Communication, Diabetes in seniors, Diabetes 
Medication.  
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Chapter 1  
1 Introduction 
In recent years, the older adult population in North America has grown quickly. 
“Population aging in Canada would accelerate between 2010 and 2031, a period during 
which all baby boomers would reach age 65” (Statistics Canada, 2010, p.16). Long life 
spans and improving medical care means aging is becoming a priority among health care 
researchers (Jeannotte & Moore, 2007) and practitioners. As a result of these 
demographic changes, it is estimated that by 2036 the number of older adults in Canada 
will range between 9.9 and 10.9 million (Statistics Canada, 2010). As the population of 
older adults in Canada grows, the number of prescriptions for health conditions and 
chronic disease also will increase. Medication misuse, poor adherence and risk of 
overdose are just some of the issues that health professionals can expect when providing 
care to older patients (The Gerontological Society of America, 2013).  
Haskard-Zolnierek and DiMatteo (2009) defined patient adherence to medical 
advice as follows: “the degree to which patients follow the recommendations of their 
health professionals” (p. 827). The term “compliance” has been replaced by “adherence” 
in recent literature (Brincat, 2012). Terms like “unfaithful” and “unreliable” can be found 
in the medical literature from the first half of the twentieth century, however, they 
implied that the physician had absolute power over the patient, instead of portraying the 
process as a shared decision between physician and patient (Steiner & Earnest, 2000). 
Although both terms “adherence” and “compliance” can be found in the literature  
“adherence presumes the patient’s agreement with the recommendations, whereas 
compliance implies patient passivity” (Brown & Bussell, 2011, p. 305). The term 
“compliance” was proposed by a group of health professionals in United Kingdom and it 
also refers to the medical consultation as a dialogue between the physician and patient 
(Bissell, May, & Noyce, 2004).  
Non-adherence happens when patients do not take their medications as prescribed 
(e.g. the patient stops taking the medication or the treatment is never started). “Poor 
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adherence to medical treatment severely compromises patient outcomes and increases 
patient mortality” (Brown & Bussell, 2011, p. 306). According to Brincat (2012), non-
adherence can be intentional or unintentional, depending on the type of barrier. For 
instance, unintentional non-adherence is related to financial causes, memory issues and 
difficulties to understand the instructions (Brincat, 2012).  
Improving medication adherence among older patients is essential in order to 
achieve positive healthcare outcomes; such as reducing hospitalization rates, reducing 
further disease complications (Starr & Sacks, 2010) and minimizing the cost of long-term 
care for patients (Krueger, Berger, & Felkey, 2005). According to the World Health 
Organization (2003): “Poor adherence to treatment of chronic diseases is a worldwide 
problem of striking magnitude. Adherence to long-term therapy for chronic illnesses in 
developed countries averages 50%. In developing countries, the rates are even lower.”(p. 
13).   
There are numerous reasons for medication non-adherence that range from age-
related problems like memory declines and sensory loss to social and financial issues 
(Murray et al., 2004), as well as the patient’s decision to stop taking the medication. 
According to the National Council on Patient Information and Education (2007), the 
dimensions that affect medication adherence can be: “social and economic factors, health 
system and health care team-related factors, therapy-related factors, condition-related 
factors and patient-related factors” (p. 9). Effective patient-provider communication is 
one of the fundamental aspects for medical care delivery; and it has been proven 
important for the optimization of medication adherence among older patients (Heisler, 
Cole, Weir, Kerr, & Hayward, 2007; Wilson et al., 2007).  
Diabetes type 2 is one of the more common chronic conditions among older adults 
with a prevalence of approximately 13% in individuals 65 years and over (Misiaszek, 
2008). Older patients with diabetes are unable to produce enough insulin or their bodies 
are unable to use it correctly. Diabetes patients are often prescribed oral agents, however, 
as the disease progresses, insulin might be required. Diabetes mellitus increases the risk 
for cardiovascular disease and is a predictor for kidney damage, blindness and non-
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traumatic amputations. It is also associated with depression (Canadian Diabetes 
Association, 2015). Even when this disease requires lifestyle changes and prescribed 
medication for adult patients, they tend to take fewer doses than prescribed (Cramer, 
2004). Since poor adherence can impact future diabetes management (Aikens & Piette, 
2013), measuring medication adherence among older patients with diabetes can inform 
health professionals about diabetes management and clinical outcomes.  
Adherence to diabetes treatment can be affected by diverse factors, however 
patients who report satisfaction with their patient-provider relationship adhere better to 
their treatment (Heisler, Bouknight, Hayward, Smith, & Kerr, 2002; Rubin, 2005). 
Although most of the literature focuses on physician-patient relationship, this study 
examined the relationship with the pharmacist as an important factor for medication 
adherence, specifically for diabetes medication. Recent studies report that the pharmacist 
is deemed as a more accessible health professional than physicians for older patients with 
diabetes, allowing for long-term relationships, trust and better communication. This 
accessibility is directly associated with better medication adherence (Rickles et al., 2015; 
Worley, 2006). Given the interaction among the multiple factors that affect diabetes 
treatment adherence and patient-pharmacist communication, determining the association 
between them could be beneficial in order to inform health professionals and enhance 
older adults’ quality of life.  
1.1 The research problem 
With 50% of patients in North America not taking their medications as they should 
(Brown & Bussell, 2011), a better understanding of medication adherence among older 
patients could be helpful to health professionals and to service providers. In addition, 
since the relationship between pharmacist and patient has an important role for the 
patient’s behavior and adherence to treatment (Donohue, Huskamp, Wilson, & 
Weissman, 2009), measuring these two variables would be significant for gaining an 
insight into the interaction between patient-provider communication and medication 
adherence. For this reason, this study investigated whether perceived patient-pharmacist 
quality of communication is associated with type II diabetes medication adherence 
(insulin and oral medications).  
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1.2 Purpose of the study 
The purpose of this study was to assess older patients’ perceived quality of 
communication with their pharmacists and to investigate whether their perception 
correlates with diabetes medication adherence. Knowing more about this relationship has 
the potential to improve diabetes care among older adults. The hypothesis of this research 
was that older adults who report a better quality relationship with their pharmacists would 
report better adherence to diabetes medication.  
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Chapter 2 
2 Literature Review  
2.1 Medication Adherence 
Medication adherence is considered a major problem worldwide, especially for older 
adults (65 and over) who take numerous medications (National Council on Patient 
Information and Education, 2007). In Canada, the proportion of older adults is increasing; 
this tendency is expected to continue in subsequent years. According to the demographic 
projections for the country: “the proportion of persons aged 65 years or over would range 
between 23% and 25% in 2036 and between 24% and 28% in 2061” (Statistics Canada, 
2010, p. 50). With a high prevalence of multimorbidity among older adults, the number 
of medication prescriptions is rising, as is the burden for the health care system. 
Multimorbidity is defined as the coexistence of two or more chronic conditions (Salive, 
2013). The use of numerous medications is known as polypharmacy. It is a serious issue 
for the health care system since it encompasses negative side effects, drug-drug 
interactions and incongruous dosing (Bushardt, Massey, Simpson, Ariail, & Simpson, 
2008). According to the Canadian Institute for Health Information, “Seniors who reported 
three or more chronic conditions were taking an average of six prescription medications 
on a routine or ongoing basis, twice as many medications as seniors with only one 
chronic condition.” (Canadian Institute for Health Information, 2011, p. 2). 
 According to the World Health Organization (2003), medication adherence can be 
defined as: “the extent to which the patient follows medical instructions” (p. 3). However, 
the term is not limited to drug prescription, but to specific behaviors as well, for instance, 
special diet, physical activity and minimizing negative habits such as smoking or 
drinking (World Health Organization, 2003). The term “adherence” has been used in 
recent literature to replace the term “compliance”, given that the first term implies that 
the patient is an active participant in the treatment process (Brown & Bussell, 2011). . 
The term compliance is related to a negative assumption towards the patients behavior, 
while the term adherence implies active decision-making and collaboration between the 
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patient and the provider (Delamater, 2006) When the patient continues the treatment over 
a period of time without exceeding the acceptable pauses established by the physician, 
the term “persistence” is used (Cramer et al., 2008).  
Optimum adherence to medical treatment is fundamental for chronic disease 
management among older patients. The more adherent the patient is, the lower the rate of 
hospitalization and mortality (Starr & Sacks, 2010).  Inappropriate support for older 
adults with a long-term prescribed drug therapy often leads to medication non-adherence 
(Murray et al., 2004). From the provider’s perspective, some signs of medication non-
adherence include the following: “the patient does not get a new prescription, does not 
refill a long-term medication as frequently as expected, stops refilling medications used 
for long-term therapy, or fails to finish an entire course of an acute medication (e.g. an 
antibiotic)” (Krueger, Berger, & Felkey, 2005, p. 329). The literature reports different 
classifications of medication non-adherence. Jimmy and Jose (2011) suggested three 
types: Primary non-adherence, non-persistence and non-conforming. In the first example, 
the patient does not fill the prescription after it is received, so the treatment is never 
initiated. Non-persistence refers to stopping the medication after the treatment has 
started. This can be caused by individual limitations, personal beliefs and different 
expectations that promote the lack of adherence. Therefore, this type of non-adherence 
can be either “unintentional” (e.g. health status, cognitive decline) or “intentional” (e.g. 
skipping doses) (Brincat, 2012). The third type, non-conforming, encompasses different 
behaviors towards the medication that affect adherence. These include, for instance, 
taking a higher or lower dosage than prescribed, skipping dosages or changing doses 
(Jimmy & Jose, 2011).  
Medication non-adherence in older patients can be influenced by a myriad of 
factors, ranging from health literacy (Lee, Yu, You, & Son, 2015) to poor knowledge of 
the medication (Barat, Andreasen, & Damsgaard, 2001), to age-related factors such as 
cognitive impairment (Campbell et al., 2016) and difficulties opening medication 
containers (Atkin, Finnegan, Ogle, & Shenfield, 1994). Recently, several authors 
(Krueger et al., 2005; Murray et al., 2004; Yap, Thirumoorthy, & Kwan, 2015) outlined 
the factors that influence medication adherence among older adults. For instance, Yap 
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and her colleagues (2015) reported five main categories, namely: (1) medication-related 
factors, (2) system-based factors, (3) patient factors, (4) physician factors and (5) other 
factors, such as lack of a caregiver. This last category encompasses factors that do not 
appear very often in the literature.  According to Yap and her colleagues, medication 
factors are related to the type of medication, dosing regimen, and drug interactions, 
among others. System-based factors refer to patient education, quality of the follow-up, 
lack of medication schedule, as well as availability of nursing care. Patient factors 
include mental and physical health, medical history, patient’s demographics and beliefs 
regarding medical treatment. With regard to physician factors, the authors located the 
following issues: lack of trust and satisfaction with medical visits, lack of involvement 
from the patient and poor physician-patient communication (Yap et al., 2015).  
Another factor that affects adherence is polypharmacy, defined as the use of 
multiple medications. Duplicated drugs (Golchin, Isham, Meropol, Vince, & Frank, 
2015), adverse side effects, drug interactions and inappropriate dosing are some of the 
negative outcomes of polypharmacy (Bushardt et al., 2008). The number of seniors who 
are taking multiple medications is increasing in Canada, and the number of medications is 
related to age, specially for patients 65 years and over (Rotermann, Sanmartin, Hennessy, 
& Arthur, 2014). Reason and colleagues (2012) analyzed data from the Canadian Survey 
of Experiences with Primary Health Care (2008) and found that 27% of older patients 
were taking five or more medications. Also, older adults who were taking numerous 
medications were more likely to receive a wrong dose or a wrong prescription from their 
provider (Reason, Terner, Moses McKeag, Tipper, & Webster, 2012).  
 
Assessing medication adherence among seniors is a concern for health 
professionals, since physical and cognitive changes, such as memory loss, might impact 
their ability to take prescribed drugs (Kessels, 2003; Raehl, Bond, Woods, Patry, & 
Sleeper, 2002). According to Salthouse (2009), even when some cognitive abilities start 
to decline slightly before the age of 30, the decline in some domains such as memory is 
significantly more evident after 60 (Salthouse, 2009).  
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 There is no standard assessment for medication adherence. However, 
measurements can be categorized according to the type of data that reflect adherence 
(quantitative or qualitative). Farmer (1999) reported different methods to measure 
medication adherence. For instance, the method of drug level in biologic fluids helps to 
determine if the patient has received the required dose of medication more accurately. 
However, it is difficult to assess the degree of compliance from one patient to another 
because two patients can have the same level of the target drug but they could have 
consumed the medication in a different way. Other methods to assess medication 
adherence include: biologic markers (similar to biologic fluids), direct patient observation 
(monitored clinical trials) and patient self-report (e.g., diaries, interviews and validated 
questionnaires), pill count (simply counting the number of dosage units like tablets or 
capsules), prescription refill records, use of electronic devices, and Meds Check program1 
(Ontario Pharmacists Association).  
Self-report is the most common assessment in clinical care (Stirratt et al., 2015), 
questionnaires related to medication adherence have numerous advantages. For instance, 
they can be used in different settings and patients can complete them easily. However, the 
accuracy of the results depends on the instrument, on how patients might interpret the 
questions differently or on how they might attempt to conceal their behaviour (Farmer, 
1999). Self-report measures were selected for this research because they are the most 
convenient and flexible method for assessing medication adherence in the health care 
context (Stirratt et al., 2015).  
2.2 Patient-provider communication 
One of the most essential physician-related factors that affects medication adherence is 
“poor communication” (Yap et al., 2015). The physician-patient relationship influences 
patient outcomes such as patient satisfaction (Linn, van Weert, van Dijk, Horne, & Smit, 
2014), adherence to treatment, recall and understanding of medical information, health 
                                                
1
 Annual consultation with the patient in which the pharmacists make sure that all the medication is taken 
properly (Ontario, Ministry of Health and Long-term Care). 
2
  “Electronic monitoring generates data on the date and time of each opening of the bottle. Such data can 
be repeated and compared over time” (Lehmann et al., 2014, p.60).  
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status and even quality of life (Ong, de Haes, Hoos, & Lammes, 1995). Physician quality 
of communication is an important aspect of medical education. However, the active 
participation of the patient during the consultation also is fundamental for a better 
understanding of the treatment information and health outcomes (Ha, Anat, & 
Longnecker, 2010; Harrington, Noble, & Newman, 2004). 
Effective communication between patient and provider is expected to result in 
appropriate delivery of medical care. Nevertheless, different communication barriers in 
clinical settings have been identified including patients leaving with unanswered 
questions after a medical visit (Zullig et al., 2015). Bartlett and colleagues (2008) found 
that adverse events in hospital could be preventable by overcoming communication 
barriers (e.g., optimizing information sharing and special attention to patients with 
disabilities). Moreover, Park and Song (2005) reported significant differences between 
older patients and nurses perceived communication barriers. The authors found that older 
patients considered: “using medical terminology”, “working without a sincere attitude”, 
“authoritative attitude”, “sudden change of subject” and “being unfriendly” as the more 
important nurse-related barriers (p. 161). 
The complex interaction between physician-patient communication and 
medication adherence has been examined for the last four decades. Hulka and colleagues 
(1976) investigated inappropriate drug use and how it was related to physician and 
patient communication. The authors found that appropriate physician-patient 
communication was associated with better adherence to the treatment among patients 
with heart failure and diabetes. They also found that communication influenced patient 
behavior during health care delivery, especially for receiving and understanding 
instructions (Hulka, Cassel, Kupper, & Burdette, 1976).  
Numerous authors have shown that a relationship exists between the quality of 
patient-provider communication and medication adherence (Brown & Bussell, 2011; 
Haskard-Zolnierek & DiMatteo, 2009; Jolles, Clark, & Braam, 2012; Martin et al., 2010; 
Ratanawongsa, Karter, Parker, Lyles, Heisler, et al., 2013; Schoenthaler et al., 2009; 
Stavropoulou, 2011; Swain, Hariharan, Rana, Chivukula, & Thomas, 2015; Zullig et al., 
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2015). Communication rated as collaborative was associated with better adherence to 
long-term treatment. Collaborative communication refers to a shared-decision making 
process between the physician and the patient, rather than unitary (Naik, Kallen, Walder, 
& Street, 2008).  
Trust is another relevant factor for the patient-provider relationship. Donohue and 
her colleagues (2009) conducted a survey among American older adult patients to 
investigate the level of trust that the patients had for their provider, and how it was 
related with prescription medications. The result from their survey showed that the 
respondents trusted physicians and pharmacists as the most reliable source of information 
about drug effectiveness and about the prices of medication (Donohue et al., 2009). The 
authors suggested that the patients’ trust in their providers has a significant impact on 
medication adherence. Moreover, the pharmacists seem to have a special position to 
support and to educate the patient about medication use (Urru, Pasina, Minghetti, & Giua, 
2015). 
Among health professionals, pharmacists have a considerable influence for 
medication adherence. Ranelli and Coward (1996) investigated the differences between 
rural and urban pharmacists concerning the interaction with older patients. They found 
that patients from rural areas communicated more often with their pharmacists than their 
urban counterparts and that they established significant relationships with their providers. 
This interaction facilitated the communication about medication issues and was thought 
to prevent and to help decrease drug management issues (Ranelli & Coward, 1996). In a 
subsequent study (1997), the authors examined patients’ expectations regarding their 
pharmacist. Older patients with higher expectations were more likely to request health 
care counseling, highlighting the significant role of communication for health outcomes 
(Ranelli & Coward, 1997).   
Effective patient-pharmacist communication has a significant role in health care. 
In this regard, Hargie and his colleagues (2000) analyzed 30-videotaped interactions 
between pharmacists and patients with the aim of identifying effective communication 
features. Pharmacists were instructed to watch the interactions and to rank the 
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communication skills based on level of importance from their perspective. The effective 
communication skills were placed in eleven categories (according to the ranking): 
building rapport (e.g. being helpful, showing concern), explaining, questioning, listening, 
non-verbal communication (e.g. eye-contact, tone of voice), suggesting/advising, opening 
(e.g. identifying patient by name), closing (e.g. being polite), assertiveness (e.g. 
enhancing credibility) to mention a few. The findings suggested that pharmacists who 
showed a higher number of these communication skills were deemed better practitioners 
(Hargie, Morrow, & Woodman, 2000). 
Several scales for assessing patient-provider communication exist. Ramsey’s 
(2000) General Practice Assessment Survey (GPAS) is used for communication and other 
dimensions of medical care like satisfaction and patient’s knowledge (Ramsay, Campbell, 
Schroter, Green, & Roland, 2000). Lerman’s (1990) Perceived Involvement in Care Scale 
(PICS) addresses the decision-making process between patient and doctor. Little’s (2001) 
questionnaire permits the researcher to explore communication, illness experience, 
patient-provider relationship, beliefs and expectations, among other factors (Little et al., 
2001). As for pharmacist-specific communication, Worley (2006) used a questionnaire to 
test the pharmacist-patient relationship quality in a random sample of 600 older adults in 
the United States. This complete tool includes numerous questions related to participative 
behavior, interpersonal communication and relationship commitment (Worley, 2006).  
2.3 Diabetes medication adherence and pharmacist 
communication 
“Diabetes is currently among the top five causes of death in most high-income countries 
and resulted in 4.6 million deaths globally in 2011” (García-Pérez, Alvarez, Dilla, Gil-
Guillén, & Orozco-Beltrán, 2013, p. 176). Canada has a high rate of diabetes in 
comparison with other nations causing a significant financial burden to the Canadian 
health system (Canadian Diabetes Association & Diabetes Québec, 2010). In fact, The 
Canadian Diabetes Association (2015) estimated that the direct cost due to diabetes was 
approximately $3 billion for 2015: $1.8 billion in medication, $721 million in hospital 
care and $717 million in physician consultations.  According to the Canadian Diabetes 
Association (2015): “There are three types of diabetes: type 1 diabetes, which generally 
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develops in childhood or adolescence, and occurs when the body does not produce insulin 
(or produces very little); type 2 diabetes occurs when the body does not make enough 
insulin or cannot properly use the insulin it produces; gestational diabetes is a temporary 
condition that develops during pregnancy and leads to increased risk of developing type 2 
diabetes for both mother and child.” (p. 11). 
Optimal glycemic control is fundamental to manage diabetes properly. In this 
regard, patients can be prescribed non-insulin antihyperglycemic agents and/or insulin 
therapy. The non-insulin antihyperglycemic agents include: DPP-4 Inhibitors (oral drugs 
that improve glucose control like linagliptin, saxagliptin, sitagliptin), GLP-1 Receptor 
Agonists (injectable drugs that stimulate insulin secretion like liraglutide), Sulfonylureas 
(drugs that stimulate the beta cells to secrete insulin, like gliclazide, glyburide), 
Meglitinides (drugs that stimulate insulin secretion with an immediate effect like 
repaglinide), Metformin (enhances insulin sensitivity), SGLT2 Inhibitors (drugs that 
enhance urinary glucose excretion like canagliflozin) and Combination formulations (e.g. 
linagliptin with metformin). Insulin therapies include: Basal insulin (e.g. determir, 
glargine), Prandial insulin (e.g. aspart, lispro), and Premixed insulin (e.g. biphasic aspart 
(Canadian Diabetes Association, 2015). Although Type 2 diabetes requires a delicate 
balance of prescribed medication and lifestyle changes, adherence to oral drugs or insulin 
is often poor and affects the management of the condition (Aikens & Piette, 2013). As a 
matter of fact, “recommended glycemic goals are achieved by less than 50% of patients, 
which may be associated with reduced adherence to therapies, and may lead to 
complications of diabetes over time” (García-Pérez et al., 2013, p.189).  
Regimen complexity is a significant factor that influences medication adherence 
in patients with diabetes. Patients who take numerous prescribed medications report low 
levels of adherence (Pasina et al., 2014). In this regard, taking both pills and injections 
increases the treatment level of complexity. Adherence can also be affected by the type of 
drugs. For instance, injectable medication is often related with lower adherence 
(Balkrishnan et al., 2003). Concerning oral hypoglycemic drugs, the number of tablets 
that the patient must take per day heavily influences adherence. Patients taking one tablet 
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per day (e.g. metformin) show better adherence than those who take two or more 
(Donnan, MacDonald, & Morris, 2002; Morningstar, Sketris, Kephart, & Sclar, 2002).  
Diabetes medication adherence continues to be a problem for patients and the 
health care system, especially for seniors. In Canada, the diabetes prevalence is higher 
among older adults. According to the 2015 Report on Diabetes, by 2010, 49% of patients 
were 65 years of age and older, and among the newly diagnosed group 39% of new cases 
were reported for individuals 50 to 64 years old (Canadian Diabetes Association, 2015). 
A high levels of medication adherence offers numerous benefits for older adults such as 
better glycaemic control over time, lower medication costs and fewer diabetes 
complications and hospital visits (Capoccia, Odegard, & Letassy, 2015).  
Older patients with diabetes require pharmacotherapy to achieve glycaemic 
control. Therefore, adherence to the treatment is fundamental in order to manage their 
disease successfully and improve the patients’ quality of life (Krass, Schieback, & 
Dhippayom, 2014). Older patients face numerous barriers to diabetes management such 
as comorbidities, lack of knowledge of the disease, age-related changes, financial 
problems, lack of social support, adherence to medications and inadequate 
communication with health professionals (Hammouda, 2011). Moreover, older patients 
are more likely to develop diabetes complications and to suffer depressive symptoms, 
which can significantly affect medication adherence (Kim et al., 2015). 
Type 2 diabetes medication adherence can be greatly affected by the perceived 
patient-provider quality of communication (Heisler et al., 2002). Regrettably, 
approximately 63% of healthy Canadians have never talked about diabetes with their 
physician (Canadian Diabetes Association, 2015a). Furthermore, poor communication 
with providers is associated with low adherence to oral hypoglycemics, to refilling 
prescriptions and to monitoring glucose levels (Ciechanowski, Katon, Russo, & Walker, 
2001; Ratanawongsa, Karter, Parker, Lyles, Heisler, et al., 2013).  
Older patients with diabetes establish significant long-term relationships with 
different providers like physicians and nurses, also pharmacists are often more accessible 
to address medication related problems (Worley, 2006). There is a significant association 
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between the pharmacist-patient relationship and glycaemic control (Collins, Limone, 
Scholle, & Coleman, 2011). Pharmacists are able to reduce adverse drug effects, increase 
knowledge about diabetes and improve medication adherence in older patients (Alhabib, 
Aldraimly, & Alfarhan, 2014; Butt, Mhd Ali, Bakry, & Mustafa, 2016; Grossman, 2011; 
Hassali, Nazir, Saleem, & Masood, 2015; Omran, Guirguis, & Simpson, 2012). The 
influence of pharmacist-patient communication has been shown to be a crucial factor 
concerning diabetes medication adherence among older patients. Hence, ineffective 
communication can lead to medication non-adherence, which can cause negative health 
outcomes in older adults with diabetes (Rickles et al., 2015).  
Additional research regarding adherence to diabetes medication and patient-
pharmacist communication would be useful to inform health professionals about older 
adults’ medication behaviour. Moreover, since “more than 10% of emergency department 
visits in Canada result from drug-related problems” (Tannenbaum & Tsuyuki, 2013, 
p.1229), exploring medication adherence among seniors might be helpful to providers, 
specially pharmacists, considering that older patients tend to have a continuous 
interaction with their pharmacists and this connection improves with age (Dragic et al., 
2015).  
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Chapter 3
3 Methodology 
3.1 Participants and design 
The present study is quantitative and uses a cross-sectional design. A convenience sample was 
used. The sample consisted of 84 patients from the Primary Care Diabetes Support Program at 
the St. Joseph’s Family Medical and Dental Centre, in London Ontario, Canada. This clinic 
offers a multidisciplinary team of health professionals who provide support for individual with 
diabetes. Patients attending this clinic have access to specialized nurse practitioners, physicians 
and dieticians. A sample of 84 participants was sufficient to detect a correlation of 0.30 with a 
power of 80 percent (Cohen, 1988). The inclusion criteria for the participants were: ≥60 years, 
diagnosed with type 2 diabetes, taking at least one long-term medication for this condition, 
English-speaking, no visual or hearing problems, as well as no diagnosis of dementia. All the 
participants had had at least one previous appointment at the clinic.  
According to a Report of Diabetes in Canada: “The sharpest increase in the prevalence of 
diabetes occurs after the age of 40” (Public Health Agency of Canada, 2011). Also, from 1988 to 
2010 the prevalence of diabetes significantly increased in the age group ≥65 years old (Cheng et 
al., 2013). Considering this information, a minimal age of 60 was set as the criteria for 
recruitment for patients with diabetes. Regarding medication, it is estimated that from 2008 to 
2010 85.1% of adults with diabetes were taking at least one oral medication, insulin injections or 
both (Public Health Agency of Canada, 2011). For this study, patients were required to be taking 
at least one diabetes-related medication. This study was approved by Western Ethics Board and 
the Clinical Research Impact Committee and Lawson Administration (Please refer to Appendix 
A). 
3.2 Instruments 
For this research, the following assessment tools were used: 
a) The Morisky’s Medication Adherence Scale (MMAS 8) (Morisky DE, Green LW, 
1986). This medication adherence instrument was developed by Morisky and 
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colleagues on 2008 to assess patients with hypertension. This tool has a sensitivity 
of 93% and specificity of 53%, with alpha reliability of 0.83 (Morisky, Ang, 
Krousel-Wood, & Ward, 2008). This questionnaire assesses the level of 
medication adherence for each participant. Eight questions are each answered 
“yes” or “no”, with “yes” scored as 1 and “no” as zero; except for item number 5, 
in which “yes” scores zero and “no” scores 1.  The adherence level can be 
determined based on a score from 0 to 8. A score under 6 represents low 
adherence, scores from 6 to 7 represent medium adherence and a score of 8 
represents high adherence. This adherence scale is used commonly in clinical 
settings for different diseases (Tan, Patel, & Chang, 2014) It was chosen to offer 
participants a short questionnaire that they could fill quickly.  (Please refer to 
Appendix B for a copy of the questionnaire) 
b) The Pharmacist-Patient Relationship Quality Model Questionnaire (Worley, 2006) 
consists of 43 items, with alpha reliability of 0.76. Each question is answered on a 
Likert Scale in order to test the quality of the relationship between the patient and 
the pharmacist from the patient’s perspective. The tool incorporates five 
constructs:  
• Pharmacist participative behavior (reliability α = 0.95) 
• Patient participative behavior (α = 0.91) 
• Pharmacist-patient interpersonal communication (α = 0.90) 
• Relationship quality (α = 0.93) 
• Relationship commitment (α = 0.76)  
Participants are asked questions about their relationship with their pharmacist. 
They are required to answer on a scale from 1 (strongly disagree) to 5 (strongly 
agree). A 9 is included as a “does not apply” option. If the data contains 20% or 
more missing items and “does not apply” items in the questionnaire, these data 
were removed from the scoring in accordance with the scoring protocol of the 
scale. For each question scores range from 1 to 5 with a higher score representing 
a stronger relationship between the pharmacist and the patient. The final score was 
obtained adding all the participant’s answers and dividing them by the number of 
items in the questionnaire (43), with the maximum final score being 5. This scale 
  
 
17 
was chosen because it was developed to assess older adults with diabetes. Further, 
the scale contains questions worded in such manner that optimizes 
comprehension. Moreover the response is not complicated (Please refer to 
Appendix C for a copy of the questionnaire).  
c) A demographic questionnaire was administered to collect the following 
information from participants: year of birth, gender, level of education, time 
diagnosed with diabetes, type of medication currently taking (pills, injections or 
both), and time filling the prescription with the same pharmacist. The participant 
could also indicate if a different pharmacist assisted them each time the 
prescription was filled (Please refer to Appendix D for a copy of the demographic 
questionnaire).  
3.3 Procedure 
Morisky’s Medication Adherence Scale (MMAS 8) (Morisky DE, Green LW, 1986), and the 
Pharmacist-Patient Relationship Quality Questionnaire (Worley, 2006) were used to test 84 
participants at a single point in time. The procedure follows: 
1) The patient arrived to the clinic and proceeded to the front desk.  
2) The clinic receptionist determined if the patient was a potential participant based on 
the eligibility criteria (age, diabetes medication, etc.).  
3) The patient was given a clinic consent form regarding research and clinical trials. On 
the form they were asked to indicate whether he or she would agree to be contacted 
about research.  
4) After checking in for their appointment and signing the clinic consent form, the 
participant was asked by the receptionist if he or she would have some time to 
participate in a research study conducted by a Western student.  
5) If the participants agreed, they were given a letter of information and consent form 
(Please see Appendix E), the demographic information form and the two self-
administered questionnaires.  
6) The participant filled out the demographic information and completed the 
questionnaires during their waiting time. Although waiting times were often long, the 
participant could decide to drop out of the study by the time of the appointment, 
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without finishing it. The participant could also complete the questionnaires after the 
appointment. In order to ensure an anonymous process while collecting the data, a 
drop box was placed in the waiting room. Participants were informed about the drop 
box and the importance of anonymity, however, some participants felt uncomfortable 
with this instruction and asked the student if she could receive the questionnaire 
personally. The student received the questionnaires from the participants who felt 
uncomfortable using the drop box. The student was always present in the waiting 
room during the data collection process, in order to answer all the participants’ 
questions about the study.   
7) After each day of data collection, the student reviewed the information and separated 
incomplete or empty questionnaires from the complete ones.  A total of 96 patients 
volunteered to participate in the study and filled out the questionnaires. However, 
during the data collection process, 12 questionnaires were considered unusable and 
were removed. See the next paragraph in which the reasons for removing these files 
were outlined. For anonymity purposes, all removed data was place in a confidential 
waste container according to the requirements of the clinic.  
8) After the number of participants was achieved, the student proceeded to read the last 
set of questionnaires and forms to keep identifying missing data or blank 
questionnaires. Following the removal of 12 questionnaires, the student returned to 
the clinic to get 12 new participants and achieve the required number based on the 
calculations for the required sample size.  
From all data collected, 12 questionnaires were removed because of the following 
reasons: 
a) Missing data or empty questionnaires. 20% or more of missing items and “does not 
apply” items in the Pharmacist-Patient Relationship Quality Model Questionnaire. 
b)  A patient had a diagnosis of dementia. This information was given to the student by 
the patient’s relative after the person finished the questionnaire. The clinic staff also 
confirmed this information so the participant’s data were removed.  
c) A patient had a diagnosis of schizophrenia. In this case the patient agreed to 
participate and completed the questionnaire before the appointment. However, later 
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that day, the nurse in charge of the patient informed the student about the 
schizophrenia diagnosis and the data were removed. 
d) A patient refused to continue the questionnaire after completing half of it and declared 
that the questions were too difficult. The participant gave the questionnaire to the 
student before her appointment and the data were removed.   
3.4 Data Analyses  
Data analyses were carried out using the Statistical Package for the Social Sciences (SPSS) 
software version 2.0. Pearson correlations were calculated to measure the association between 
the medication adherence overall score and the quality of pharmacist-patient relationship overall 
score. In addition, the questionnaires’ scores were correlated with: (1) Age, (2) Years of formal 
education, (3) Years diagnosed with diabetes, (4) Number of Medications, (5) Time filling the 
prescription with the same pharmacist measured in years, (6) Gender,  (7) Medication Type 
(pills, injections or both). 
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Chapter 4 
4 Results  
The participant’s mean age was 68.3 years, ranging from 60 to 89 years. Men constituted 60% of 
the sample while women represented 40% of the sample. Regarding education, 52% of the 
participants completed college/university studies, 30% completed high school, 9% had a 
Master’s or PhD degree, 5% attended middle school only and 4% reported completing 
elementary school as their highest level of education. Participants reported an average of 16.0 
years since being diagnosed with diabetes, ranging from 1 year to 52 years. The average time 
with their pharmacist was 9.67 years. Some participants reported that they had been filling their 
prescriptions with the same pharmacist even before they were diagnosed with diabetes. However, 
for the purpose of this study, only time filling diabetes medication prescriptions was considered. 
Concerning diabetes-.related medication, 43% of the patients reported taking both pills and 
injections, 38% reported only using pills, while 19% stated taking injections only. All 
participants used pens instead of syringes for diabetes medication injections. For the present 
research no medication brands were considered, as most patients just answered “pills” or 
“injections” in their demographic questionnaires. The study sample corresponded to a specific 
population of older adults who have access to diabetes care program. The descriptive data are 
summarized in Table 1 below. Please see Appendix F for a complete summary of the data 
collected.  
 
 
Descriptive Statistics       
 N Minimum Maximum Mean St. 
Deviation 
 
Age 84 60 89 68.31 6.569  
Table 1 Descriptive Statistics 
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Years of Formal 
Education 
 
84 
 
5 
 
18 
 
14.23 
 
3.079 
 
 
Years diagnosed with 
diabetes 
 
84 
 
1.0 
 
52.0 
 
16.042 
 
9.1941 
 
 
Number of Medications 
 
Time with the 
Pharmacist  
 
Pharmacist-Patient 
Relationship Score 
 
84 
 
84 
 
84 
 
1 
 
2 
 
2.12 
 
2 
 
25 
 
5.00 
 
1.42 
 
9.67 
 
4.1751 
 
.496 
 
5.972 
 
.67986 
 
 
Medication Adherence 
Score 
 
Valid N (listwise) 
 
84 
 
 
84 
 
2.00 
 
8.00 
 
6.7649 
 
1.35012 
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The statistical analyses indicated that there was a positive correlation of r=0.162, p>.05 
between the medication adherence score and the quality of pharmacist-patient relationship score. 
Contrary to expectations, the variables were not significantly correlated. The Medication 
Adherence score was not significantly correlated with age (r= 0.15, p> .05) or with the time with 
the pharmacist (r= -0.045, p>.05). However, a significant negative correlation was found 
between medication adherence and years diagnosed with diabetes (r= -0.233 p<. 05). This 
finding suggests that a patient who had been taking diabetes medication for a longer period of 
time reported to be less adherent to their treatment in comparison with someone who was more 
recently diagnosed.  
The quality of the pharmacist-patient relationship was not significantly correlated with 
the time with the pharmacist (r= 0.024, p>.05), the years diagnosed with diabetes (r= 0.012, 
p>.05), or with the age of the participant (r= -0.118, p>.05). Also, the number of years of 
education was not significantly correlated with medication adherence (r=-0.074, p>.05) or with 
the quality of the pharmacist-patient relationship (r= -0.194, p>.05).  
After the first statistical analysis, the medication adherence scores were divided in two 
categories: high adherence (8 points) and low adherence (less than 8 points). A significant 
correlation was found between the medication adherence score and the number of medications 
the patient is taking (r= -0.284, p=0.01). This result shows that patients who were taking just one 
medication (pills only or injections only) reported better adherence than participants who were 
taking both pills and injections as part of their diabetes treatment. A Chi Square (please see 
Table 2) was conducted to examine the relation between low or high adherence and the number 
of medications taken by the participant (1 medication represents pills or injections only, while 2 
medications represents for both pills and injections). As shown in table 2, the level of adherence 
is associated with the number of medication types that the patient is taking. That is, participants 
taking two types of diabetes medications are less adherent than those who take only one type.  
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A t-Test (see Table 3) was performed to compare sex differences for medication 
adherence and pharmacist-patient quality of relationship. Even though, women (M=6.9118, 
SD=1.14297) were slightly more adherent than men (M=6.6650, SD=1.47739), no significant 
difference was found, t (82)= -0.821, p > 0.5. In general, 26.2% of participants reported low 
adherence, 34.54% reported medium adherence and 39.3% reported high adherence. Concerning 
the pharmacist-patient quality of relationship score male participants reported a slightly better, 
but not statistically different t (82)= 0.320, p > 0.5 quality of relationship with their pharmacists 
(M=4.1948, SD= 0.71988), than female participants (M=4.1462, SD= 0.62578). 
Table 2 Chi Square Test 
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Table 3 T-Test 
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Chapter 5 
5 Discussion 
Results from the present study show that the medication adherence score was not 
significantly correlated with the pharmacist-patient quality of relationship score. This 
finding is not consistent with the existing literature, which shows the existence of an 
association between communication and adherence. Previous studies considered that the 
quality of patient-provider communication is a relevant factor for medication adherence 
in general (Haskard-Zolnierek & DiMatteo, 2009; Martin et al., 2010; Schoenthaler et al., 
2009; Stavropoulou, 2011; Swain et al., 2015; Zullig et al., 2015) and for diabetes-
specific medication adherence (Ciechanowski et al., 2001; Ratanawongsa, Karter, Parker, 
Lyles, Warton, et al., 2013).  
The fact that no statistically significant association was found between the 
medication adherence score and the pharmacist-patient quality of relationship score could 
be related to the setting in which the data were collected. A study by White and 
colleagues (2012) found that patients from diabetes primary care showed high adherence 
to hypoglycemic medication, indicating that diabetes specialized clinics contribute to a 
significant improvement in diabetes medication adherence (White et al., 2012). The 
present research was conducted using patients who visited the Primary Care Diabetes 
Support Program, which offers multidisciplinary teams of health professionals who focus 
on helping patients manage their diabetes. This innovative primary health care model 
offers access to two full-time nurse practitioners, two part-time nurses, three physicians, 
two dietitians and one social worker; patients with no family physician receive assistance 
to find a family doctor (Reichert, Harris, & Harvey, 2014). On this matter, the diabetes 
management support received by the patients who attend this clinic might influence 
adherence. That is, since the clinic works alongside the pharmacists to make sure 
prescriptions are filled in time, the quality of the relationship with the provider may be 
influenced by this continuous interaction.  
 No statistically significant associations were found between the medication 
adherence score or the pharmacist-patient quality of relationship score vs. age, time with 
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the pharmacist, and level of education. Concerning education level and medication 
adherence, these findings differ from other studies. For instance, Bakar and colleagues 
(2016) found that participants with high levels of education were more adherent than 
those with primary school or no formal education at all (Bakar, Fahrni, & Khan, 2016). 
The participants in this study were highly educated (i.e., 9% had a Master’s or PhD 
degree, while 50% of the sample had completed university studies) whereas 55.2% of 
participants in Bakar’s study had secondary education, and 12.1% had completed college 
or university. The literature shows that patients with higher levels of education are more 
inclined to be adherent to their diabetes treatment; also, patients who had completed 
graduate school were 41% more likely to be adherent (Kirkman et al., 2015). Since 61% 
of the participants in the present study reported college-level education or higher, a 
highly educated sample may have affected the correlation between education and 
medication adherence. Given that patients with a higher level of education were more 
inclined to participate in the study, in comparison with patients with a lower level of 
education, it should be noted that these highly educated participants might not represent 
the total patient population of the clinic.  
 Concerning the sex differences, the present research found no significant 
difference between women and men with respect to the medication adherence score and 
the pharmacist-patient quality of relationship score. This result is congruent with some of 
the existing literature (Donnan et al., 2002; Osborn & Gonzalez, 2016; Sirey, Greenfield, 
Weinberger, & Bruce, 2013). Geisel-Marbaise and Stummer (2009) suggested that, since 
adherence can be influenced by numerous factors there is no gender patter for diabetes 
medication adherence; according to the authors: “A patient’s decision for or against 
adherence seems to be influenced by so many individual factors that it implies profound 
multidimensionality”(Geisel-Marbaise & Stummer, 2009, p.225). The present study 
results differ from other findings that suggest men report better adherence than women 
(Curkendall, Thomas, Bell, Juneau, & Weiss, 2013; Kirkman et al., 2015; Rolnick, 
Pawloski, Hedblom, Asche, & Bruzek, 2013; Vietri et al., 2016). Also, male participants 
represented 60% of the sample and the results may have been affected by the lack of 
female participants. Regarding the discrepant findings in the literature, Curkendall and 
colleagues (2013) considered that differences between women and men could be 
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explained by the different types of diabetes medications that each study examined as well 
as sex differences in medication interactions and side effects (Curkendall et al., 2013). 
 A significant negative correlation was found between the medication adherence 
score and the years that the patient had been diagnosed with diabetes. This association is 
not congruent with previous research. For example, Kirkman and colleagues (2015) 
indicated that patients who were new to diabetes treatment were less adherent to the 
treatment. Additionally, some older adults may present diabetes progression and 
complications, which eventually can result and more prescriptions and affect medication 
adherence (Jarab et al., 2014). Another factor that could have influenced the negative 
correlation between the medication adherence score and years diagnosed with diabetes is 
the intense diabetes monitoring that the patients receive at the clinic when they are newly 
diagnosed. If the patient achieves the optimal glycemic control, the appointments with the 
physician will be less frequent. Recently diagnosed patients are followed-up more 
intensively and they can be seen at the clinic once a week until the diabetes education is 
covered. In the present study as the patient improves, appointments occur every six 
months. In this way, less frequent visits may affect diabetes medication adherence.  
 In the present study no association between medication adherence score and age 
was found. Other studies suggest that older individuals report higher adherence. For 
instance, Kirkman and her colleagues indicated that the age group of 45-64 years was 
more adherent than the group 20 to 44 years old (Kirkman et al., 2015). Regarding age, 
Curkendall and colleagues found that adults 65 and over are more adherent than their 
younger counterparts (Curkendall et al., 2013). In a review by Jin and colleagues (2008), 
the authors indicated that numerous studies found that older patients have higher rates of 
adherence than younger groups. The authors suggested that although older patients might 
face more barriers for adherence (e.g. vision or hearing difficulties, difficulties to open 
bottles or swallow pills), if they get support from caregivers and health providers, they 
are more likely to be highly adherent (Jin, Sklar, Min Sen Oh, & Chuen Li, 2008).  
 The time that the participants had been filling their prescription with the same 
pharmacist was expected to have a significant correlation with the medication adherence 
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score and the pharmacist-patient quality of relationship score. Even though the average 
time that the participants reported with their pharmacist was very high, no correlation was 
found between this variable and the medication adherence score and the pharmacist-
patient quality of relationship score. The clinical setting of the study could have 
influenced the high pharmacist-patient quality of relationship scores reported by the 
participants. Keshishian and her colleagues found that community-dwelling older adults 
who attend metropolitan pharmacies reported to be less satisfied with the quality of the 
relationship with their pharmacists (Keshishian, Colodny, & Boone, 2008). In contrast, 
older adults who receive care at the diabetes clinic might benefit from the continuous 
communication between the clinic and the pharmacy.  
The present study found a significant negative correlation between the medication 
adherence score and the number of medications that the patient was taking. Patients who 
reported to be taking both insulin and pills as part of their treatment had a lower 
medication adherence score than the patients who were taking one type of medication 
only (pills or injections). This association has been found in previous studies. For 
instance, Barat and colleagues (2001) found that the number of medications could be 
deemed as a predictor for medication non-adherence (Barat et al., 2001). Pasina and 
colleagues (2014) tested medication adherence in a sample of older adults who had been 
discharged from internal medicine and after a follow up, the authors found an association 
between a high number of medications and a lower adherence (Pasina et al., 2014). In this 
regard, findings from the present research suggest that the combination of pills and 
injections for diabetes treatment could be detrimental for adherence. 
Introducing new medications during the course of a treatment might also impact 
the patterns of adherence (Curkendall, Thomas, Bell, Juneau, & Weiss, 2013b). The more 
complex the treatment, the lower will be the level of adherence (Shah, Desai, Gajjar, & 
Shah, 2013; Vries et al., 2014). The medication adherence score in this research could be 
related to pharmacologic management of diabetes, in which the introduction of new 
medications is required until the patient achieves the optimal glycemic control. The 
participants from this study who had more years diagnosed with diabetes, could have 
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been experiencing diabetes progression and receiving more prescriptions, which 
eventually could influence overall adherence.  
According to the Prevention and Management of type 2 Diabetes in Adults (2015) 
adapted from the Canadian Diabetes Association (2013), at diagnosis of diabetes type 2, 
the patient must start with a lifestyle intervention (including physical activity and 
nutritional changes) as well as pills (e.g. metformin). The amount of pills that the patient 
is required to take will change according to the glycemic target. If glycemic control is not 
achieved in two or three months, the dose can be increased. The patient characteristics 
determine what type of medication will be added next (for instance, degree of 
hypoglycemia, overweight patient, renal problems); subsequently, if the glycemic target 
is still not achieved, the guidelines suggest adding insulin injections to oral agents or 
intensify the pills regimen (Canadian Diabetes Association, 2015). As these guidelines 
suggest, the diabetes treatment can become more complex while achieving glycemic 
control. In this regard, taking only oral agents or only injections as treatment could be 
easier to maintain in comparison with patients who must take multiple injections a day, 
along with the oral agents.  
The results of this study correspond to a sample of participants who are receiving 
diabetes care in a specialized clinic and findings might differ if the same method was 
applied to a sample of older adults from a rural community (Martin et al., 2010), a 
hospital (Swain et al., 2015), or a sample obtained from survey data (Ratanawongsa, 
Karter, Parker, Lyles, Heisler, et al., 2013; Stavropoulou, 2011). The follow-up that the 
diabetes clinic offers in order to monitor patients’ progress is a valuable service that 
could influence the participants’ perceptions regarding diabetes medication and 
communication with pharmacists, as well as improving treatment adherence. The study 
participants receive care from physicians, nurse practitioners and dieticians specialized in 
diabetes. For this reason, the lack of variability in the scores (See Figure 1 and Figure 2) 
and the presence of high adherence could be related to the integral service that is 
provided in this clinic. This study shows the relevance of diabetes specialized clinics and 
the importance of intense patient follow-up and monitoring as a valuable way to improve 
medication adherence among older patients diagnosed with diabetes. 
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Figure 1 
Figure 2 
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5.1 Limitations 
The present study had several limitations. As a cross-sectional study, the findings are 
limited to a specific moment in time. All the participants were part of the Primary Care 
Diabetes Support Program, consequently, the results might not be generalizable to other 
health care settings or populations with no access to a clinic specialized in diabetes.  
Several factors were not included in the present study:  
a) Comorbidities. For the present study, only diabetes was included, however, it 
should be pointed out that adherence might be different in seniors who have 
diabetes only in comparison with seniors who also have hypertension, 
dyslipidemia, etc.  
b) Acute management vs. chronic management of diabetes.  
c) The exact daily dosing (both for pills and injections) of every patient and the 
specific brands that they were using.  
d) Patients’ strategies to adhere to their treatments  
e) Individual domains in the Pharmacist-Patient Quality of Relationship 
Questionnaire.  
f) Over the counter (OTC) medications and non-prescribed supplements. 
g) The presence of depression was not tested. Depression may affect self-care 
among diabetes patients (Park, Katon, & Wolf, 2013). 
h) Marital status of the participants, economic status and disease-specific social 
support. Higher levels of social support and good relationships with family 
members can impact positively adherence to treatment (Delamater, 2006).  
i) The participants’ health literacy, which has been associated with adherence in 
general and poor glycemic control (Geboers et al., 2015; Jones, Treiber, & 
Jones, 2014; Kirk et al., 2011; Souza et al., 2014). 
Another limitation is the medication adherence and provider communication 
assessment through self-reported questionnaires. Even though self-reported measures are 
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less time consuming and less complex for older patients, the information may not be 
completely accurate as patients might overestimate their own adherence and try to 
conceal any negative behaviors. Moreover, the patient could misinterpret the questions or 
present difficulty to recall medication specific details. In this regard, the study results 
correspond only to what the participants reported and the additional information provided 
by the clinic. It is acknowledged that self-reported measurements may not be as accurate 
as other types of assessments such as electronic measures2, pharmacy refills and 
prescription claims databases (Lehmann et al., 2014).  
5.2 Future Research  
Future research should recruit participants from different settings in order to compare 
patients from a specialized clinic to those who have no access to diabetes care, as well as 
patients who manage their diabetes under the supervision of their family physician. In 
this study, more than half of the patients reported high adherence to their diabetes 
treatment and it would have been informative to compare adherence among clinic 
patients and seniors with no access to this type of clinic.  
Approximately 80% of people with diabetes take natural products along with their 
prescribed medications (Canadian Diabetes Association, 2015). In future studies, it would 
be relevant to consider other prescribed medications that the patient might be taking, as 
well as natural products, supplements and medications over the counter.  
The specific tools used to assess medication adherence and pharmacist-patient 
communication heavily influenced the results. Some participants said that the 
Pharmacist-patient Quality of Relationship questionnaire was too long. Future research 
should consider different assessment tools to more comprehensively study the 
relationship between medication adherence and pharmacist-patient communication.  
                                                
2
  “Electronic monitoring generates data on the date and time of each opening of the bottle. Such data can 
be repeated and compared over time” (Lehmann et al., 2014, p.60).  
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Given that patients in urban areas are likely to interact with different pharmacists 
when filling a prescription, future studies should consider assessing the pharmacist-
patient relationship in terms of satisfaction with the pharmacy in general, as well as 
consider the pharmacists’ viewpoint in order to identify how the pharmacist and the 
patient work as a team to manage diabetes.   
5.3 Conclusions 
This research explored the correlation between medication adherence and pharmacist-
provider quality of communication in a sample of 84 older adults at the Primary Care 
Diabetes Support Program at the St. Joseph’s Family Medical and Dental Centre. This 
study did not find a correlation between the medication adherence score and the 
pharmacist-patient relationship quality score. This result corresponds to a population who 
have access to a clinic specialized in diabetes. Most participants reported high adherence 
and good quality of communication with their pharmacists, which could be related to the 
intensive diabetes monitoring they receive at the clinic. Results showed that patients who 
take both insulin and pills tend to report lower adherence to treatment. On this matter, 
health professionals should pay special attention to patients taking both medications to try 
to decrease the potential burden for the individual. Patients who have been diagnosed 
with diabetes for a long time also reported lower levels of adherence in comparison with 
the more recently diagnosed. Therefore, more attention should be given to these patients 
to prevent poor adherence.  
Despite several limitations, the present study emphasizes the importance of long-
term diabetes follow-up even when the patient has been diagnosed for many years. This 
research also highlights the importance of intense monitoring for patients who take both 
pills and insulin in order to identify non-adherence. Furthermore, the study suggests that 
pharmacists may play an important position into improving senior’s diabetes 
management.  
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APPENDIX B 
Morisky Medication Adherence Scale:  
Please answer the following questions thinking ONLY about your diabetes medication 
MMAS‐8 
Instructions: Please answer YES or NO to the following questions 
 
1) Do you sometimes forget to take your medication? YES     NO   
 
2) People sometimes miss taking their medications for reasons other than forgetting. 
Thinking over the past two weeks, were there any days when you did not take 
your medicine? YES     NO   
 
3) Have you ever cut back or stopped taking your medicine without telling your 
doctor because you felt worse when you took it?  YES     NO   
 
4) When you travel or leave home, do you sometimes forget to bring along your 
medicines?   YES     NO   
5) Did you take all your medicine yesterday? YES     NO   
  
6) When you feel like your symptoms are under control, do you sometimes stop 
taking your medicine? YES     NO   
 
7) Taking medicine everyday is a real inconvenience for some people? Do you ever 
feel hassled about sticking to your treatment plan? YES     NO   
 
8) How often do you have difficulty remembering to take all your medicine? 
___A. Never / Rarely 
___B. Once in a while 
___C. Sometimes 
___D. Usually 
___E. All the time 
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APPENDIX C  
Please answer the following questions thinking ONLY about your diabetes medication: 
My pharmacist: Never 
1 
Rarely 
2 
Every once 
in a while 
3 
Sometimes 
4 
Always 
5 
Does not 
apply 
9 
Advises me about how to 
monitor myself for 
medication side effects 
1 2 3 4 5 9 
Advises me about my 
medication(s) even if I do not 
have medication questions 
1 
 
2 3 4 5 9 
Advises me about whether or 
not is okay for me to take my 
medication(s) with over-the-
counter products 
1 2 3 4 5 9 
Expresses interest to work 
with me to meet my health 
care needs 
1 2 3 4 5 9 
Expresses a desire to help me 
manage my medication 
1 2 3 4 5 9 
Questions me to be sure I 
understand how to properly 
use my medication(s) before I 
leave the pharmacy 
1 2 3 4 5 9 
Expresses a desire to help me 
deal with my medication 
concerns 
1 2 3 4 5 9 
Shows concern about my 
medication needs 
1 2 3 4 5 9 
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Listens to me when I have a 
medication question (s) 
1 2 3 4 5 9 
Asks me my opinion about 
how I think my medication 
regimen is working for me 
1 2 3 4 5 9 
Is easily approachable to 
discuss my medication (s) 
1 2 3 4 5 9 
Is attentive to my medication 
needs 
1 2 3 4 5 9 
Me as a patient: Definitely 
would not 
1 
Not really 
 
2 
Undecided 
 
3 
Somewhat 
Would 
4 
Definitely 
would 
5 
Does not 
apply 
9 
I would like to discuss 
medication problems I am 
having with my pharmacist 
1 2 3 4 5 9 
I keep my pharmacist up to 
date regarding any changes in 
my health condition (s) 
1 2 3 4 5 9 
I would tell my pharmacist 
about herbal medications I am 
taking with my prescription 
medication (s) 
1 2 3 4 5 9 
I would tell my pharmacist 
about over-the-counter 
medications I am taking with 
my prescription medication 
(s) 
1 2 3 4 5 9 
I would tell my pharmacist if I 1 2 3 4 5 9 
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experienced side effects to 
any of my medication (s) 
I would inform my 
pharmacist of any drug 
allergies I have 
1 2 3 4 5 9 
I would inform my 
pharmacist if I were getting 
prescription medications form 
another pharmacy 
1 2 3 4 5 9 
Me as a patient: Never 
 
1 
Rarely 
 
2 
Every once 
in a while  
3 
Sometimes 
 
4 
Always 
 
5 
Does not 
apply 
9 
I work with my pharmacist to 
manage my medication(s) 
1 2 3 4 5 9 
I get all of my prescription 
refills on time 
1 2 3 4 5 9 
I express a desire to my 
pharmacist that I would like 
him or her to help me deal 
with health care needs 
1 2 3 4 5 9 
If I do not understand 
something about my 
medication therapy, I ask my 
pharmacist to address my 
concerns 
1 2 3 4 5 9 
If the pharmacist who usually 
helps me with my medication 
is busy, I will wait until he or 
she is available to discuss my 
medication concerns 
1 2 3 4 5 9 
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If I have a medication 
question, I will call my 
pharmacist to discuss it with 
him or her 
1 2 3 4 5 9 
My pharmacist: Never 
 
1 
Rarely 
 
2 
Every once 
in a while 
3 
Sometimes 
 
4 
Always 
 
5 
Does not 
apply 
9 
Greets me at the prescription 
counter and takes my 
prescription information from 
me 
1 2 
 
3 4 5 9 
Says “hello” to me when I 
visit the pharmacy 
1 2 3 4 5 9 
Hands me my prescription 
when it is ready 
1 2 3 4 5 9 
I initiate a conversation with 
my pharmacist when I am at 
the pharmacy 
1 2 3 4 5 9 
I say “hello” to my 
pharmacist when I visit the 
pharmacy 
1 2 3 4 5 9 
In general: Strongly 
disagree 
1 
Somewhat 
disagree 
2 
Undecided 
3 
Somewhat 
agree 
4 
Strongly 
agree 
5 
Does not 
apply 
9 
My pharmacist is trustworthy 1 2 3 4 5 9 
I trust that my pharmacist will 
alert my physician of any 
problems with the 
 
1 
 
2 
 
3 
 
4 
 
5 
 
9 
  
 
61 
combination of drugs that I 
am taking 
There are times when my 
pharmacist seems insincere 
1 2 3 4 5 9 
My pharmacist always puts 
my best interests first 
1 2 3 4 5 9 
I am satisfied with my 
pharmacist 
1 2 3 4 5 9 
I receive useful information 
about my medication(s) from 
my pharmacist 
1 2 3 4 5 9 
I value the services that my 
pharmacist provides to me 
1 2 3 4 5 9 
I am grateful for the 
individualized attention I 
receive from my pharmacist 
1 2 3 4 5 9 
It is important to me to take 
my prescription to the same 
pharmacist or group of 
pharmacist whenever I get a 
prescription filled 
1 2 3 4 5 9 
If I had a general health 
related question that did not 
require me to obtain a 
prescription, I would rely on 
my pharmacist for advice 
related to these matters 
1 2 3 4 5 9 
If a less expensive pharmacy 
opened near my present 
pharmacy, I would change 
1 2 3 4 5 9 
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pharmacies  
I plan to use my current 
pharmacist to meet my 
prescription  
1 2 3 4 5 9 
If a more convenient 
pharmacy location opened I 
would start going to that 
pharmacy. 
1 2 3 4 5 9 
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APPENDIX D  
Demographic Information Form 
1. Year of birth: ____________________ 
2. Gender:    Female       Male   
3. Level of education: 
Elementary School   
Middle School   
High School   
College   
Master/PhD   
4. How long have you been diagnosed with diabetes?  
 
 
5. What type of medication do you take for diabetes? 
 
 
6. How long have you been filling your prescription with the same pharmacist? 
______________________________________________________________________ 
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APPENDIX E 
 
 
LETTER OF INFORMATION 
 
Perceived patient-pharmacist communication and diabetes management: assessing 
medication adherence among older patients 
 
PRINCIPAL INVESTIGATOR:  
Dr. Alan Salmoni  
MASTER’S STUDENT: 
 Cecilia Flores-Sandoval  
COMMITTEE MEMBERS: 
Dr. Joseph B. Orange  
Dr. Rob Petrella  
 
 
You are being invited to participate in this research study about pharmacist 
communication and diabetes medication adherence because you are an older adult with 
diabetes. Improving medication adherence among older patients can lead to positive 
health outcomes, reducing complications and hospitalization rates. Numerous barriers 
affect medication adherence, including patient and pharmacist communication. The 
literature has shown that effective communication with the pharmacist has a positive 
impact on the patient treatment adherence. In the case of diabetes, patients who report a 
good communication with their pharmacist often show a better adherence to their 
medications. 
 
Your participation in this study is voluntary. You may decide not to be in this study, or to be 
in the study now and then change your mind later. You may leave the study at any time 
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without affecting your care. You may refuse to answer any question you do not want to 
answer. This study is completely independent from health care in this clinic, doctors, 
nurses and clinic staff. All data collected during this study will be confidential, 
participation is completely anonymous and the personal data will not be linked to the 
questionnaire answers. If you get called before you finish your participation you may 
withdraw from the study and your data will be discarded, this will not affect your health 
care. 
 
Data will be kept in an encrypted portable device and only the research team members 
will have access to it. All data (electronic and paper) will be kept for 15 years in 
accordance with Lawson Policy. 
This study is about how seniors with diabetes perceive their communication with their 
pharmacist and whether this affects adherence to diabetes medication. This study will 
help to understand the importance of pharmacist’s communication to ensure that patients 
with diabetes are able to take their diabetes medications correctly.  
Your participation in the study is required only on this one occasion.  
If you decide to participate, you will be asked to complete a demographic data form and 
two brief questionnaires. Filling out the questionnaires will take you no longer than 30 
minutes. You may refuse to answer any question you do not want to answer.  
You will be asked to fill the following: 
 
1. Demographic Information Form  (year of birth, gender, level of education, how 
long have you been taking medication for diabetes and what type of medication, 
time you have been filling your prescription with in the same pharmacist). 
 
2. Medication Adherence Scale (12 Yes/No Questions about your diabetes 
medication habits) Please fill this questionnaire keeping in mind ONLY your 
diabetes medication. 
 
3. Pharmacist-Patient Relationship Questionnaire (you will rate how do you 
perceive your relationship and communication with your pharmacist in a scale 
from 1 to 5) Please fill this questionnaire keeping in mind ONLY your diabetes 
medication.  
There are no known risks for participating in this study. There are no known benefits to 
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you associated with your participation in this research study, although we hope the 
recommendations we make may help future pharmacist-older adult communication in 
general. There are no costs for participating. If you decide to participate, you are free to 
withdraw your consent at any moment and ask as many questions as you like.  
Completing the questionnaire and placing it in the drop box located in the waiting 
room implies consent to participate in this study.  
Representatives of The University of Western Ontario’s Health Sciences Research Ethics 
Board may require access to your study-related records to monitor the conduct of the 
research. You do not waive any legal rights by participating in this study.  
Representatives of Lawson Quality Assurance Education Program may require access to 
your study-related documents to ensure that proper laws and guidelines are being 
followed. 
Participation in this study is anonymous. All data collected will be kept confidential and 
access will be restricted to the researchers named above. If you have any questions about 
the study or if you wish to receive the results via e-mail please feel free to contact us.  
If you have any questions about your rights as a research participant or the conduct of this 
study, you may contact Dr. David Hill, Scientific Director, Lawson Health Research 
Institute. 
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APPENDIX F 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
Table 4  
Table 5  
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Descriptives 
 Statistic Std. Error 
Age Mean 68.31 .717 
95% Confidence 
Interval for Mean 
Lower Bound 66.88  
Upper Bound 69.74  
5% Trimmed Mean 67.86  
Median 67.00  
Variance 43.156  
Std. Deviation 6.569  
Minimum 60  
Maximum 89  
Table 6  
Table 7 
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Range 29  
Interquartile Range 9  
Skewness .864 .263 
Kurtosis .467 .520 
Years of Formal 
Education 
Mean 14.23 .336 
95% Confidence 
Interval for Mean 
Lower Bound 13.56  
Upper Bound 14.89  
5% Trimmed Mean 14.48  
Median 16.00  
Variance 9.478  
Std. Deviation 3.079  
Minimum 5  
Maximum 18  
Range 13  
Interquartile Range 4  
Skewness -1.236 .263 
Kurtosis 1.274 .520 
Years diagnosed with 
diabetes 
Mean 16.042 1.0032 
95% Confidence 
Interval for Mean 
Lower Bound 14.046  
Upper Bound 18.037  
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5% Trimmed Mean 15.492  
Median 15.000  
Variance 84.531  
Std. Deviation 9.1941  
Minimum 1.0  
Maximum 52.0  
Range 51.0  
Interquartile Range 10.0  
Skewness 1.077 .263 
Kurtosis 2.023 .520 
Number of Medication 
Types 
Mean 1.42 .054 
95% Confidence 
Interval for Mean 
Lower Bound 1.31  
Upper Bound 1.52  
5% Trimmed Mean 1.41  
Median 1.00  
Variance .246  
Std. Deviation .496  
Minimum 1  
Maximum 2  
Range 1  
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Interquartile Range 1  
Skewness .344 .263 
Kurtosis -1.928 .520 
Time_Pharmacist Mean 9.67 .652 
95% Confidence 
Interval for Mean 
Lower Bound 8.37  
Upper Bound 10.96  
5% Trimmed Mean 9.21  
Median 9.00  
Variance 35.671  
Std. Deviation 5.972  
Minimum 2  
Maximum 25  
Range 23  
Interquartile Range 11  
Skewness .920 .263 
Kurtosis -.034 .520 
Pharmacist-Patient 
Relationship Score 
Mean 4.1751 .07418 
95% Confidence 
Interval for Mean 
Lower Bound 4.0276  
Upper Bound 4.3227  
5% Trimmed Mean 4.2248  
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Median 4.3600  
Variance .462  
Std. Deviation .67986  
Minimum 2.12  
Maximum 5.00  
Range 2.88  
Interquartile Range .95  
Skewness -1.037 .263 
Kurtosis .393 .520 
Medication Adherence 
Score 
Mean 6.7649 .14731 
95% Confidence 
Interval for Mean 
Lower Bound 6.4719  
Upper Bound 7.0579  
5% Trimmed Mean 6.8935  
Median 7.0000  
Variance 1.823  
Std. Deviation 1.35012  
Minimum 2.00  
Maximum 8.00  
Range 6.00  
  
 
73 
Interquartile Range 2.25  
Skewness -1.165 .263 
Kurtosis 1.160 .520 
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